Genetic Variants at the ITPA Locus Protects Against Ribavirin-induced Hemolytic Anemia and Dose Reduction in an HCV G2/G3 cohort
Arne Nørgaard Eskesen, Espen Melum, Amir Moghaddam, Kristian Bjøro, Kristian Verbaan, Olav Dalgaard, Eskesen AN, Melum E, Moghaddam A, Bjøro K, Verbaan H, Ring-Larsen H, Dalgard O
Dyk ned i forskningsemnerne om 'Genetic Variants at the ITPA Locus Protects Against Ribavirin-induced Hemolytic Anemia and Dose Reduction in an HCV G2/G3 cohort'. Sammen danner de et unikt fingeraftryk.